The University of Oxford revealed Monday that a COVID-19 vaccine it’s established with AstraZeneca is 70.4?fective in preventing individuals from establishing symptoms, per interim data from Phase 3 trials. It is much more affordable than other vaccines in development and is part of the international COVAX initiative, developed to make sure doses go where they’re most needed.
Yes, but: The Food and Drug Administration initially set the bar for a COVID-19 vaccine to be 50%reliable, approximately in line with the seasonal influenza vaccine.
https://covid19globalcases.com/oxford-university-coronavirus-vaccine-up-to-90ficient/
Comments
Post a Comment